As of 2025-12-27, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 15.5x | 15.3x |
| Forward P/E multiples | 19.8x - 35.5x | 22.2x |
| Fair Price | (29.02) - (22.23) | (27.43) |
| Upside | -175.9% - -158.2% | -171.8% |
| Date | EV/EBITDA |